FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361815032> ?p ?o ?g. }

• W4361815032 abstract "<p>Supplementary Figure 1 shows more details on the mode of action and design of the used antibodies. Supplementary Figure 2 displays additional APC activation data of the human and murine FAP-CD40 molecules. Supplementary Figure 3 shows additional data for FRC in vitro assays and the OVA vaccination study. Supplementary Figure 4 shows additional data on the in vivo study comparing FAP-huCD40 and SGN40 moIgG1. Supplementary Figure 5 displays additional data on the in vivo comparison of selicrelumab and FAP-huCD40. Supplementary Figure 6 shows the data of a FAP-huCD40 dose escalation study in cynomolgus monkeys.</p>" @default.
• W4361815032 created "2023-04-05" @default.
• W4361815032 creator A5002042787 @default.
• W4361815032 creator A5002226100 @default.
• W4361815032 creator A5005225268 @default.
• W4361815032 creator A5015837678 @default.
• W4361815032 creator A5016075040 @default.
• W4361815032 creator A5016320178 @default.
• W4361815032 creator A5021326463 @default.
• W4361815032 creator A5024188748 @default.
• W4361815032 creator A5026289091 @default.
• W4361815032 creator A5026544482 @default.
• W4361815032 creator A5026955443 @default.
• W4361815032 creator A5032847382 @default.
• W4361815032 creator A5038802855 @default.
• W4361815032 creator A5040318787 @default.
• W4361815032 creator A5041981120 @default.
• W4361815032 creator A5056208445 @default.
• W4361815032 creator A5056556748 @default.
• W4361815032 creator A5060412049 @default.
• W4361815032 creator A5065468159 @default.
• W4361815032 creator A5066305023 @default.
• W4361815032 creator A5076327726 @default.
• W4361815032 creator A5077770252 @default.
• W4361815032 creator A5077791294 @default.
• W4361815032 creator A5080071412 @default.
• W4361815032 creator A5081708347 @default.
• W4361815032 creator A5083188070 @default.
• W4361815032 creator A5086504935 @default.
• W4361815032 date "2023-03-31" @default.
• W4361815032 modified "2023-09-27" @default.
• W4361815032 title "Supplementary Figures 1-6 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity" @default.
• W4361815032 doi "https://doi.org/10.1158/1078-0432.22480199.v1" @default.
• W4361815032 hasPublicationYear "2023" @default.
• W4361815032 type Work @default.
• W4361815032 citedByCount "0" @default.
• W4361815032 crossrefType "posted-content" @default.
• W4361815032 hasAuthorship W4361815032A5002042787 @default.
• W4361815032 hasAuthorship W4361815032A5002226100 @default.
• W4361815032 hasAuthorship W4361815032A5005225268 @default.
• W4361815032 hasAuthorship W4361815032A5015837678 @default.
• W4361815032 hasAuthorship W4361815032A5016075040 @default.
• W4361815032 hasAuthorship W4361815032A5016320178 @default.
• W4361815032 hasAuthorship W4361815032A5021326463 @default.
• W4361815032 hasAuthorship W4361815032A5024188748 @default.
• W4361815032 hasAuthorship W4361815032A5026289091 @default.
• W4361815032 hasAuthorship W4361815032A5026544482 @default.
• W4361815032 hasAuthorship W4361815032A5026955443 @default.
• W4361815032 hasAuthorship W4361815032A5032847382 @default.
• W4361815032 hasAuthorship W4361815032A5038802855 @default.
• W4361815032 hasAuthorship W4361815032A5040318787 @default.
• W4361815032 hasAuthorship W4361815032A5041981120 @default.
• W4361815032 hasAuthorship W4361815032A5056208445 @default.
• W4361815032 hasAuthorship W4361815032A5056556748 @default.
• W4361815032 hasAuthorship W4361815032A5060412049 @default.
• W4361815032 hasAuthorship W4361815032A5065468159 @default.
• W4361815032 hasAuthorship W4361815032A5066305023 @default.
• W4361815032 hasAuthorship W4361815032A5076327726 @default.
• W4361815032 hasAuthorship W4361815032A5077770252 @default.
• W4361815032 hasAuthorship W4361815032A5077791294 @default.
• W4361815032 hasAuthorship W4361815032A5080071412 @default.
• W4361815032 hasAuthorship W4361815032A5081708347 @default.
• W4361815032 hasAuthorship W4361815032A5083188070 @default.
• W4361815032 hasAuthorship W4361815032A5086504935 @default.
• W4361815032 hasBestOaLocation W43618150321 @default.
• W4361815032 hasConcept C150903083 @default.
• W4361815032 hasConcept C154317977 @default.
• W4361815032 hasConcept C185592680 @default.
• W4361815032 hasConcept C202751555 @default.
• W4361815032 hasConcept C207001950 @default.
• W4361815032 hasConcept C39347974 @default.
• W4361815032 hasConcept C55493867 @default.
• W4361815032 hasConcept C71924100 @default.
• W4361815032 hasConcept C86803240 @default.
• W4361815032 hasConcept C98274493 @default.
• W4361815032 hasConceptScore W4361815032C150903083 @default.
• W4361815032 hasConceptScore W4361815032C154317977 @default.
• W4361815032 hasConceptScore W4361815032C185592680 @default.
• W4361815032 hasConceptScore W4361815032C202751555 @default.
• W4361815032 hasConceptScore W4361815032C207001950 @default.
• W4361815032 hasConceptScore W4361815032C39347974 @default.
• W4361815032 hasConceptScore W4361815032C55493867 @default.
• W4361815032 hasConceptScore W4361815032C71924100 @default.
• W4361815032 hasConceptScore W4361815032C86803240 @default.
• W4361815032 hasConceptScore W4361815032C98274493 @default.
• W4361815032 hasLocation W43618150321 @default.
• W4361815032 hasLocation W43618150322 @default.
• W4361815032 hasOpenAccess W4361815032 @default.
• W4361815032 hasPrimaryLocation W43618150321 @default.
• W4361815032 hasRelatedWork W1566729005 @default.
• W4361815032 hasRelatedWork W2138350991 @default.
• W4361815032 hasRelatedWork W2409285845 @default.
• W4361815032 hasRelatedWork W2416964709 @default.
• W4361815032 hasRelatedWork W2433311123 @default.
• W4361815032 hasRelatedWork W2434195791 @default.
• W4361815032 hasRelatedWork W2953758866 @default.
• W4361815032 hasRelatedWork W3015376786 @default.
• W4361815032 hasRelatedWork W3165143150 @default.
• W4361815032 hasRelatedWork W4254591511 @default.
• W4361815032 isParatext "false" @default.

• next